Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 11 September 2001
Vol. 2001, Issue 99, p. tw322
[DOI: 10.1126/stke.2001.99.tw322]


Receptor Transactivation Crosstalk at the Membrane

The epidermal growth factor receptor (EGFR) can become activated when other membrane receptors bind to their cognate ligands. For example, when platelet-derived growth factor (PDGF) binds to its receptor (PDGFR), the EGFR becomes phosphorylated on tyrosine. Saito et al. report that this transactivation may occur at the plasma membrane of vascular smooth muscle cell. A complex containing endogenous EGFR and PDGFR subunits was detected, even in the absence of PDGF treatment. Stimulation of cells with PDGF caused simultaneous activation of both receptor types, but did not increase heterodimer formation. PDGFR kinase activity was not required for EGFR transactivation. Because inhibition of Src kinase activity blocked heterodimer formation, the authors propose that Src phosphorylates a protein in the receptor complex that is critical for maintaining heterodimer association. The proposed model suggests that PDGF induces homodimerization of the PDGFR, but that associated EGFRs may not necessarily homodimerize.

Y. Saito, J. Haendeler, Y. Hojo, K. Yamamoto, B.C. Berk, Receptor heterodimerization: Essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol. Cell Biol. 21, 6387-6394 (2001). [Abstract] [Full Text]

Citation: Crosstalk at the Membrane. Sci. STKE 2001, tw322 (2001).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882